FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
19/09/2025
Voltar para busca
Dado oficial do USPTO
GUTSEER
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Snapshot rápido
ST13
US500000079382092Classe
5, 9, 10, 35, 37, 41, 42, 44
Pedido
79382092
Registro
7691245
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
31
Atualização mais recente
03/04/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 9, 10, 35, 37, 41, 42, 44
Data de depósito
17/07/2023
Data de registro
18/02/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
18/02/2025
Última transação
03/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
5
Tipo de titular
99
Localização do titular
CN
Examinador
RATCLIFFE, ROBERT L
Unidade examinadora
L90
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
SINGLERA GENOMICS (CHINA) LTD.
Representantes
Timothy T. Wang Ni, Wang & Massand, PLLC
Classificação técnica
Classes Nice
Classe 5Classe 9Classe 10Classe 35Classe 37Classe 41Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Medicines for human purposesmedicines for gene therapy and cancer diseases; pharmaceutical preparations for the treatment of gene and cancer diseases; diagnostic preparations for medical purposes; biological preparations for the treatment of cancergene therapygenetic testing; chemical preparations for the treatment of cancergene therapygenetic testing; depuratives for the body; diagnostic preparations for veterinary purposes; pesticides; medical dressings; dietetic substances adapted for medical purposesdietetic preparations adapted for medical purposes
Classe 9
bioreactors for cell culturing for scientific research
Classe 10
tomographs for medical purposes; surgical apparatus and instruments; apparatus for DNA and RNA exams for medical purposes; biomagnetic rings for therapeutic or medical purposes; surgical implants comprised of artificial materials; suture materials
Classe 35
Retail store services for pharmaceuticalveterinary and sanitary preparations and medical supplies; wholesale store services for pharmaceuticalveterinary and sanitary preparations and medical supplies; advertising services; organization of exhibitions for commercial or advertising purposes; marketing services; import-export agency services; systemization of information into computer databases; provision of an on-line marketplace for buyers and sellers of goods and services; sponsorship search
Classe 37
installationmaintenance and repair of computer hardware; machinery installationmaintenance and repair; sterilization of medical instruments; upholstering
Classe 41
publication of books; on-line publication of electronic books and journals; organization of exhibitions for cultural or educational purposes; mobile library services
Classe 42
Technological research in the field of cancer diseasegene expressiongenetic testinggene therapygene editing technology and related medicines; scientific research in the nature of conducting clinical trials for others in the field of cancer diseasegene expressiongenetic testinggene therapygene editing technology and related medicines; biological research; bacteriological research; medical research; medical researchcancer research for medical purposes; platform as a service (PAAS) featuring computer software platforms for use in medical diagnosis and analysis; chemical analysis; culturing of cells for others for scientific research purposes; genetic testing for scientific research purposes
Classe 44
Medical clinic services; medical screening; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical assistance; advisory services related to health; medical equipment rental; rental of sanitary installations; nutritional guidance related to diet; sanatorium services; providing cancer screening services
Publicações
Histórico de despachos e eventos da marca no USPTO.
31 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
31/08/2025
FIMP
FINAL DISPOSITION PROCESSED
31/08/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
18/05/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
19/04/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
31/03/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
31/03/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
18/02/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
18/02/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
31/12/2024
PUBO
PUBLISHED FOR OPPOSITION
31/12/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
25/12/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/12/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
29/11/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
26/11/2024
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
26/11/2024
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
11/11/2024
GNFR
FINAL REFUSAL E-MAILED
11/11/2024
CNFR
FINAL REFUSAL WRITTEN
11/11/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
16/10/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
15/10/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
15/10/2024
RFNT
REFUSAL PROCESSED BY IB
14/05/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
19/04/2024
RFRR
REFUSAL PROCESSED BY MPU
19/04/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/04/2024
CNRT
NON-FINAL ACTION WRITTEN
01/04/2024
DOCK
ASSIGNED TO EXAMINER
22/03/2024
MAFR
APPLICATION FILING RECEIPT MAILED
11/11/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/11/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/11/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace GUTSEER ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.